TipRanks on MSN

C4 Therapeutics Presents Phase 1 Trial Data

An announcement from C4 Therapeutics ( ($CCCC) ) is now available. On October 16, 2025, C4 Therapeutics announced the presentation of data from ...
Nasdaq

C4 Therapeutics Reports Promising Cemsidomide Data in Multiple Myeloma and Announces Strategic Development Priorities

C4 Therapeutics, Inc. (C4T) announced promising results from the latest data on its investigational drug cemsidomide for treating multiple myeloma, showing a 50% overall response rate (ORR) at the ...